Stock Comparison
INSM vs REGN
Insmed Inc and Regeneron Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$22.41B
$66.35B
P/E (TTM)
—
15.5
Forward P/E
16.4
14.1
Price/Sales
27.3
4.5
Price/Book
31.8
2.1
EV/EBITDA
-6.1
10.5
Dividend Yield
—
0.58%
Profitability
Net Margin
-144.40%
29.60%
Operating Margin
-65.50%
20.70%
Return on Equity
-294.50%
14.50%
Return on Assets
-31.10%
6.13%
Growth (YoY)
Revenue Growth
229.60%
19.00%
Earnings Growth
0.00%
-7.20%
Price & Risk
Beta
0.8
0.2
52-Week High
$212.75
$818.90
52-Week Low
$90.39
$516.07
Analyst Target
$197.05
$833.31
Compare INSM and REGN your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.